Axon Seminar Cell-based Therapies Wednesday 18 April 2012
The seminar addressed current and future EU legal and regulatory developments relevant to cell-based therapies. In particular, the seminar focused on how to choose and support the right regulatory pathway for a product and seeing that through on a multinational basis.
Speakers and their presentations:
Eliane Schutte, Signifix: Advanced Therapy Medicinal Products;
Carine van den Brink, Axon Lawyers: Latest Developments in Biotech Patents;
Alex Denoon, Denoon Legal & Erik Vollebregt, Axon Lawyers: Cell Based Therapies Legal & Regulatory